Clinical value of second opinions in oncology: A retrospective review of changes in diagnosis and treatment recommendations
Authors:
- Allison Lipitz‐SnydermanALAllison Lipitz‐Snyderman
- Susan ChimonasSCSusan Chimonas
- Sham MailankodySMSham Mailankody
- Anuja KriplaniAKAnuja Kriplani
- Leonard B. SaltzLSLeonard B. Saltz
- Smita SihagSSSmita Sihag
- Carlyn Rose TanCTCarlyn Rose Tan
- Maria WidmarMWMaria Widmar
- Marjorie ZaudererMZMarjorie Zauderer
- Saul WeingartSWSaul Weingart
Open Access
- 3 February 2023
- journal article
- review article
- Published by Wiley in Cancer Medicine
- Vol. 12 (7) , 8063-8072
Abstract
Background: Data on the clinical value of second opinions in oncology are limited. We examined diagnostic and treatment changes resulting from second opinions and the expected impact on morbidity and prognosis.Methods: This retrospective cohort study included patients presenting in 2018 to a high‐volume cancer center for second opinions about newly diagnosed colorectal, head and neck, lung, and myeloma cancers or abnormal results. Two sub‐specialty physicians from each cancer type reviewed 30 medical records (120 total) using a process and detailed data collection guide meant to mitigate institutional bias. The primary outcome measure was the rate of treatment changes that were “clinically meaningful”, i.e., expected to impact morbidity and/or prognosis. Among those with treatment changes, another outcome measure was the rate of clinically meaningful diagnostic changes that led to treatment change.Results: Of 120 cases, forty‐two had clinically meaningful changes in treatment with positive expected outcomes (7 colorectal, 17 head and neck, 11 lung, 7 myeloma; 23–57%). Two patients had negative expected outcomes from having sought a second opinion, with worse short‐term morbidity and unchanged long‐term morbidity and prognosis. All those with positive expected outcomes had improved expected morbidity (short‐ and/or long‐term); 11 (0–23%) also had improved expected prognosis. Nine involved a shift from treatment to observation; 21 involved eliminating or reducing the extent of surgery, compared to 6 adding surgery or increasing its extent. Of the 42 with treatment changes, 13 were due to clinically meaningful diagnostic changes (1 colorectal, 5 head and neck, 3 lung, 4 myeloma; 3%–17%) .Conclusions: Second‐opinion consultations sometimes add clinical value by improving expected prognoses; more often, they offer treatment de‐escalations, with corresponding reductions in expected short‐ and/or long‐term morbidity. Future research could identify subgroups of patients most likely to benefit from second opinions.Keywords
Funding Information
- National Institutes of Health (P30 CA008748)
This publication has 30 references indexed in Scilit:
- Evaluation of Outcomes From a National Patient-initiated Second-opinion ProgramThe American Journal of Medicine, 2015
- Advancing the science of measurement of diagnostic errors in healthcare: the Safer Dx frameworkBMJ Quality & Safety, 2015
- Patient-Initiated Second Opinions: Systematic Review of Characteristics and Impact on Diagnosis, Treatment, and SatisfactionMayo Clinic Proceedings, 2014
- Temporal Trends in Rates of Patient Harm Resulting from Medical CareNew England Journal of Medicine, 2010
- Effectiveness of telemedicine: A systematic review of reviewsInternational Journal of Medical Informatics, 2010
- Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinionsWorld Journal of Urology, 2010
- Discrepancy between second and first opinion in surgical oncological patientsEuropean Journal of Surgical Oncology, 2006
- Cancer Patients Seeking a Second Surgical Opinion: Results of a Study on Motives, Needs, and ExpectationsJournal of Clinical Oncology, 2003
- Quality assurance of second opinion pathology in gynecologic oncologyObstetrics & Gynecology, 1999
- Incidence of Adverse Events and Negligence in Hospitalized PatientsNew England Journal of Medicine, 1991